Lantern Pharma EPS Diluted from Discontinued Operations (Quarterly) Analysis

Lantern Pharma, Inc. (LTRN)

3.59 +0.17 (+4.97%) USD | NASDAQ | Jan 20, 16:00

3.50 -0.09 (-2.51%) After-Hours: 20:00

View EPS Diluted from Discontinued Operations (Quarterly) for LTRN.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View EPS Diluted from Discontinued Operations (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View EPS Diluted from Discontinued Operations (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View EPS Diluted from Discontinued Operations (Quarterly) Benchmarks

Start Trial

NovaBay Pharmaceuticals, Inc.	Upgrade
Palatin Technologies, Inc.	--
Theriva Biologics, Inc.	--
Oragenics, Inc.	--
NanoViricides, Inc.	--